Research Division, Institute of Mental Health, Singapore, Singapore.
Neuroscience and Mental Health Programme, Lee Kong Chian School of Medicine, Singapore, Singapore.
Hum Vaccin Immunother. 2023 Aug 1;19(2):2235964. doi: 10.1080/21645515.2023.2235964. Epub 2023 Jul 25.
Singapore has one of the highest COVID-19 vaccination rates, however identifying vaccine-hesitant sub-groups and their concerns is vital given the need for future boosters in vulnerable populations. Furthermore, vaccine hesitancy remains a concern in the event of an emergence of a newer strain that necessitates the rolling out of a new vaccination programme. The aims of this study were to establish the extent of COVID-19 vaccine hesitancy and the factors influencing it among adults in Singapore using the Vaccine Hesitancy Scale (VHS). The study used a longitudinal methodology and participants were recruited in two waves from May 2020 to Sep 2022. In all 858 participants agreed to participate in both waves of the study. The two-factor structure of the VHS scale as established in earlier studies was tested using confirmatory factor analysis. The results revealed a two-factor structure of VHS comprising "lack of confidence" and "risks". Those who had higher stress, resilience, and concerns that they might be infected with COVID-19 at wave 1 were significantly associated with lower 'lack of confidence' scores i.e. lower vaccine hesitancy. In comparison, those with higher concerns about inadequate government preventive measures and unemployment at wave 1 were significantly associated with higher 'lack of confidence' scores. Those with higher concerns about inadequate government preventive measures in wave 1 were significantly associated with higher 'risks' scores i.e. higher vaccine hesitancy. The findings point toward the need for a nuanced messaging that considers the fears expressed by the populace and addresses them directly using clear simple language.
新加坡的 COVID-19 疫苗接种率位居全球前列,然而,鉴于未来在弱势群体中需要加强接种,确定疫苗犹豫亚群及其关注的问题至关重要。此外,如果出现新的变异株需要推出新的疫苗接种计划,疫苗犹豫仍然是一个令人担忧的问题。本研究旨在使用疫苗犹豫量表(VHS)评估新加坡成年人对 COVID-19 疫苗的犹豫程度及其影响因素。该研究采用纵向方法,于 2020 年 5 月至 2022 年 9 月分两波招募参与者。共有 858 名参与者同意参加两波研究。使用验证性因子分析检验了 VHS 量表在先前研究中建立的两因素结构。结果表明,VHS 量表由“缺乏信心”和“风险”两个因素组成。在第 1 波时,那些压力较大、适应力较强且担心自己会感染 COVID-19 的人,与较低的“缺乏信心”得分(即较低的疫苗犹豫)显著相关。相比之下,在第 1 波时对政府预防措施不足和失业的担忧较高的人,与较高的“缺乏信心”得分显著相关。在第 1 波时对政府预防措施不足的担忧较高的人,与较高的“风险”得分显著相关(即更高的疫苗犹豫)。这些发现表明,需要有针对性的信息传递,考虑到民众表达的恐惧,并使用清晰简单的语言直接解决这些问题。